Brief: AngioDynamics Initiates Clinical Trial Assessing AlphaVac F18 System In Treatment Of Pulmonary Embolism
19/09/2024 22:41
Sept 19 (Reuters) - AngioDynamics Inc ANGO.O :
* ANGIODYNAMICS INITIATES RECOVER-AV CLINICAL TRIAL
ASSESSING
ALPHAVAC F18⁸⁵ SYSTEM IN TREATMENT OF PULMONARY EMBOLISM AND
LONG-TERM FUNCTIONAL OUTCOMES
Source text for Eikon: ID:nBw5CM65Xa
Further company coverage: ANGO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AngioDynamics
See all newsAngioDynamics, Inc. reports results for the quarter ended August 31 - Earnings Summary
AngioDynamics Q1 sales beat on med tech segment growth
AngioDynamics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
AngioDynamics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
AngioDynamics Inc reports results for the quarter ended May 31 - Earnings Summary